VERTEX PHARMACEUTICALS INC / MA Operating Income 2008-2025 | VRTX
What is operating income?
Operating income can be defined as profit from core business operations, calculated as gross profit minus operating expenses, before interest and taxes.
What is VERTEX PHARMACEUTICALS INC / MA's current operating income?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual operating income for 2025 was $4.17B, a 1891.88% increase from 2024. VERTEX PHARMACEUTICALS INC / MA operating income for the quarter ending December 31, 2025 was $1.21B.
What was VERTEX PHARMACEUTICALS INC / MA's operating income in 2024?
VERTEX PHARMACEUTICALS INC / MA annual operating income for 2024 was $-232.9M, a 106.08% decline from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's operating income in 2023?
VERTEX PHARMACEUTICALS INC / MA annual operating income for 2023 was $3.83B, a 11.04% decline from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year operating income CAGR?
VERTEX PHARMACEUTICALS INC / MA operating income grew at a compound annual growth rate (CAGR) of 7.88% from FY2020 to FY2025, going from $2.86B to $4.17B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $4.17B | +1891.9% | 10-K |
| FY2024 | $-232.9M | -106.1% | 10-K |
| FY2023 | $3.83B | -11.0% | 10-K |
| FY2022 | $4.31B | +54.8% | 10-K |
| FY2021 | $2.78B | -2.6% | 10-K |
| FY2020 | $2.86B | +138.5% | 10-K |
| FY2019 | $1.20B | +88.5% | 10-K |
| FY2018 | $635.1M | +415.4% | 10-K |
| FY2017 | $123.2M | +1140.4% | 10-K |
| FY2016 | $9.9M | +102.1% | 10-K |
| FY2015 | $-466.9M | +32.6% | 10-K |
| FY2014 | $-692.4M | -13.5% | 10-K |
| FY2013 | $-610.0M | -1405.5% | 10-K |
| FY2012 | $46.7M | -58.9% | 10-K |
| FY2011 | $113.8M | +116.4% | 10-K |
| FY2010 | $-696.1M | -13.4% | 10-K |
| FY2009 | $-614.0M | -32.7% | 10-K |
| FY2008 | $-462.7M | - | 10-K |